Th2-high asthma: a heterogeneous asthma population?
نویسندگان
چکیده
Results Cubic Clustering Criterion, pseudo F and t statistics revealed a twoand a six-cluster model. The first cluster (n=23) was found in both models and consists of patients who present with an “IL-5-high and IL-17F-high” profile. Patients with an “IL-4or IL-13-high” profile did not cluster in one single group. In the six-cluster model, the “IL-17F-low” group was divided into 5 separate clusters: “IL-5-high” profile (n=7), “IFN-g-high” profile (n=15), “IL-6and/or TNF-high” profile (n=15), “IL-22-high” profile (n=15) and those patients that were low for all preceding cytokines (n=130; cluster 6). “IL-17Fand IL-5-high” patients had significantly lower FEV1 and higher sputum neutrophils. Patients that were only “IL-4or IL-13-high” (cluster 6) had highest FENO levels and sputum eosinophils. Conclusion Th2-high asthma can be subdivided in patients with “IL-5-high and IL-17F-high” asthma and those with “IL4or IL-13-high” asthma. The inflammatory pattern is different between both groups. The former group is characterized by mixed granulocytic airway inflammation whereas the latter group consists of patients with eosinophilic airway inflammation.
منابع مشابه
Which biomarkers are effective for identifying Th2-driven inflammation in asthma?
Recognition of asthma as a heterogeneous disease revealed different potential molecular targets and urged the development of targeted, customized treatment modalities. Evidence was provided for different inflammatory subsets of asthma and more recently, further refined to T helper (Th)2-high and Th2-low subphenotypes with different responsiveness to standard and targeted pharmacotherapy. Given ...
متن کاملHeterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma
Bronchial asthma is assumed to be the result of excessive inflammation driven by an aberrant T-helper-2 (Th2) response. Recently, it has begun to be recognized that asthma is a heterogeneous disorder. Glucocorticoids (GCs) are effective treatment for bronchial asthma; however, the inflammation in bronchial asthma cannot always be fully controlled. A recent study demonstrated a new underlying me...
متن کاملAirway Inflammatory Biomarker: Could It Tailor the Right Medications for the Right Asthmatic Patient?
Asthma is a heterogeneous disease, in which asthmatic patients present with different clinical phenotypes, variable endotypes, and different response to asthma medicines. Thus, we are faced with an asthma paradox; asthma is diagnosed subjectively by clinical history and treated with biologically active drugs. To solve this paradox, we need objective airway biomarkers to tailor the proper medica...
متن کاملSubclinical phenotypes of asthma.
PURPOSE OF REVIEW Asthma is a heterogeneous disease. Identification of specific subphenotypes of asthma may further our understanding of pathophysiology and treatment response, leading to the better targeting of both existing and novel antiasthma therapies. An accurate and comprehensive clinicopathological classification system therefore remains an important priority for asthma research. The pr...
متن کاملImmune dysregulation in children with allergic asthma, a close relationship between IL-17 but not IL-4 or IFN-, and disease severity
Background : Allergic asthma is a chronic inflammatory disease of airway that often determined with degrees of inflammation, hypersensitivity, bronchial constriction and airway changes. Th1, Th2 and Th17 cells are the main cells involved in the pathophysiology of asthma. . Therefore, this study evaluated Th1, Th2, and Th17 cells functions by assessment the expression of INF-g, IL-4, and IL-17 g...
متن کامل